Asiatic Acid Attenuates Infarct Volume, Mitochondrial Dysfunction, and Matrix Metalloproteinase-9 Induction After Focal Cerebral Ischemia
Author(s) -
Ki Yong Lee,
OkNam Bae,
Kelsey Serfozo,
Siamk Hejabian,
Ahmad Moussa,
Mathew J. Reeves,
Wilson K. Rumbeiha,
Scott D. Fitzgerald,
Gary R Stein,
SeungHoon Baek,
John L. Goudreau,
Mounzer Kassab,
Arshad Majid
Publication year - 2012
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.639427
Subject(s) - medicine , ischemia , matrix metalloproteinase , cardiology , brain ischemia , matrix metalloproteinase 9 , cerebral ischaemia , anesthesia
Asiatic acid (AA) has been shown to attenuate cerebral infarction in a mouse model of focal ischemia and shows promise as a neuroprotective stroke therapy. To facilitate translation of these findings to clinical studies, we determined pharmacokinetics, a dose-response relationship, the therapeutic time window, and efficacy using multiple stroke models. We also explored potential mechanisms of action.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom